(+)-Tetrandrine increases expression ISO RGD:1312341 6480464 tetrandrine results in increased expression of SFN protein CTD PMID:26822499 (-)-alpha-phellandrene increases expression ISO RGD:1312342 6480464 alpha phellandrene results in increased expression of SFN protein CTD PMID:24861204 (Z)-3-butylidenephthalide increases expression ISO RGD:1312341 6480464 butylidenephthalide results in increased expression of SFN protein CTD PMID:23770345 1,2-dimethylhydrazine multiple interactions ISO RGD:1312342 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of SFN mRNA] CTD PMID:22206623 1,2-dimethylhydrazine increases expression ISO RGD:1312342 6480464 1, 2-Dimethylhydrazine results in increased expression of SFN mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of SFN mRNA CTD PMID:30723492 17alpha-ethynylestradiol increases expression ISO RGD:1312342 6480464 Ethinyl Estradiol results in increased expression of SFN mRNA CTD PMID:17555576 , PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:1312342 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SFN mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO RGD:1312341 6480464 Estradiol results in increased expression of SFN mRNA CTD PMID:19167446 17beta-estradiol decreases expression ISO RGD:1312341 6480464 Estradiol results in decreased expression of SFN mRNA CTD PMID:23019147 , PMID:23094148 17beta-estradiol multiple interactions ISO RGD:1312342 6480464 [Estradiol co-treated with Progesterone] results in increased expression of SFN mRNA CTD PMID:18556351 17beta-estradiol multiple interactions ISO RGD:1312341 6480464 [Estradiol co-treated with Medroxyprogesterone Acetate co-treated with Bucladesine co-treated with decitabine] results in increased expression of SFN mRNA, [Estradiol co-treated with Medroxyprogesterone Acetate co-treated with Bucladesine] results in increased expression of SFN protein CTD PMID:22534328 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1312342 6480464 [3 more ... CTD PMID:23457121 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1312342 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SFN mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1312341 6480464 Tetrachlorodibenzodioxin results in increased expression of SFN mRNA CTD PMID:27913140 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1312342 6480464 Tetrachlorodibenzodioxin results in decreased expression of SFN mRNA CTD PMID:21354282 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1312342 6480464 Tetrachlorodibenzodioxin results in increased expression of SFN mRNA CTD PMID:19770486 2,3-dimethoxynaphthalene-1,4-dione increases expression ISO RGD:1312341 6480464 2 more ... CTD PMID:17547211 2-acetamidofluorene increases expression EXP 6480464 2-Acetylaminofluorene results in increased expression of SFN mRNA CTD PMID:19167416 , PMID:22213190 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO RGD:1312342 6480464 [3 more ... CTD PMID:23457121 4,4'-sulfonyldiphenol increases methylation ISO RGD:1312341 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of SFN promoter CTD PMID:30616060 4,4'-sulfonyldiphenol increases expression ISO RGD:1312342 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of SFN mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1312342 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of SFN mRNA CTD PMID:30951980 4-nitrophenol decreases expression ISO RGD:1312342 6480464 4-nitrophenol results in decreased expression of SFN mRNA CTD PMID:34673133 5-(hydroxymethyl)cytosine multiple interactions ISO RGD:1312341 6480464 [hydroquinone affects the methylation of SFN promoter] which results in increased abundance of 5-hydroxymethylcytosine CTD PMID:23940045 5-aza-2'-deoxycytidine decreases methylation EXP 6480464 Decitabine results in decreased methylation of SFN promoter CTD PMID:15979784 5-aza-2'-deoxycytidine multiple interactions ISO RGD:1312341 6480464 [Estradiol co-treated with Medroxyprogesterone Acetate co-treated with Bucladesine co-treated with Decitabine] results in increased expression of SFN mRNA CTD PMID:22534328 5-aza-2'-deoxycytidine increases expression EXP 6480464 Decitabine results in increased expression of SFN mRNA CTD PMID:15979784 5-aza-2'-deoxycytidine increases expression ISO RGD:1312341 6480464 Decitabine results in increased expression of SFN protein CTD PMID:22534328 , PMID:25189999 5-fluorouracil multiple interactions ISO RGD:1312341 6480464 SFN protein affects the susceptibility to [Fluorouracil co-treated with Cisplatin] more ... CTD PMID:15016801 more ... 5-fluorouracil increases expression ISO RGD:1312341 6480464 Fluorouracil results in increased expression of SFN mRNA CTD PMID:16557594 , PMID:17982676 5-fluorouracil affects expression ISO RGD:1312341 6480464 Fluorouracil affects the expression of SFN mRNA CTD PMID:16584549 5-methylcytosine multiple interactions ISO RGD:1312341 6480464 [hydroquinone affects the methylation of SFN promoter] which results in decreased abundance of 5-Methylcytosine CTD PMID:23940045 6-O-methylguanine multiple interactions ISO RGD:1312341 6480464 [O(6)-benzylguanine co-treated with O-(6)-methylguanine] results in decreased expression of SFN mRNA CTD PMID:29666243 7,12-dimethyltetraphene increases expression ISO RGD:1312341 6480464 9 more ... CTD PMID:21527772 actinomycin D increases expression ISO RGD:1312341 6480464 Dactinomycin results in increased expression of SFN mRNA CTD PMID:21527772 adefovir pivoxil increases expression ISO RGD:1312341 6480464 adefovir dipivoxil results in increased expression of SFN mRNA CTD PMID:25596134 aflatoxin B1 affects expression ISO RGD:1312341 6480464 Aflatoxin B1 affects the expression of SFN protein CTD PMID:20106945 aflatoxin B1 increases expression ISO RGD:1312341 6480464 Aflatoxin B1 results in increased expression of SFN mRNA CTD PMID:21527772 more ... all-trans-retinoic acid multiple interactions ISO RGD:1312342 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of SFN mRNA more ... CTD PMID:30951980 alpha-phellandrene increases expression ISO RGD:1312342 6480464 alpha phellandrene results in increased expression of SFN protein CTD PMID:24861204 antirheumatic drug decreases expression ISO RGD:1312341 6480464 Antirheumatic Agents results in decreased expression of SFN mRNA CTD PMID:24449571 aristolochic acid increases expression ISO RGD:1312341 6480464 aristolochic acid I results in increased expression of SFN mRNA, aristolochic acid I results in increased expression of SFN protein CTD PMID:33212167 arsane increases expression ISO RGD:1312341 6480464 Arsenic results in increased expression of SFN mRNA CTD PMID:19945496 arsenic atom increases expression ISO RGD:1312341 6480464 Arsenic results in increased expression of SFN mRNA CTD PMID:19945496 arsenous acid decreases response to substance ISO RGD:1312341 6480464 SFN protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 azathioprine increases expression ISO RGD:1312341 6480464 Azathioprine results in increased expression of SFN mRNA CTD PMID:22623647 benzalkonium chloride increases expression ISO RGD:1312342 6480464 Benzalkonium Compounds results in increased expression of SFN mRNA CTD PMID:30171875 benzene increases expression ISO RGD:1312341 6480464 Benzene results in increased expression of SFN mRNA CTD PMID:33064461 benzo[a]pyrene increases expression ISO RGD:1312341 6480464 Benzo(a)pyrene results in increased expression of SFN mRNA CTD PMID:20106945 more ... benzo[a]pyrene decreases methylation ISO RGD:1312341 6480464 Benzo(a)pyrene results in decreased methylation of SFN promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1312342 6480464 Benzo(a)pyrene results in increased expression of SFN mRNA CTD PMID:19770486 benzo[a]pyrene increases mutagenesis ISO RGD:1312341 6480464 Benzo(a)pyrene results in increased mutagenesis of SFN gene CTD PMID:25435355 Benzo[k]fluoranthene decreases expression ISO RGD:1312342 6480464 benzo(k)fluoranthene results in decreased expression of SFN mRNA CTD PMID:26377693 beta-naphthoflavone increases expression ISO RGD:1312341 6480464 beta-Naphthoflavone results in increased expression of SFN mRNA CTD PMID:19737606 bis(2-chloroethyl) sulfide increases alkylation ISO RGD:1312341 6480464 Mustard Gas results in increased alkylation of SFN protein CTD PMID:18342354 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1312341 6480464 Diethylhexyl Phthalate results in decreased expression of SFN protein CTD PMID:31163220 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SFN mRNA CTD PMID:25181051 bisphenol A multiple interactions ISO RGD:1312342 6480464 [bisphenol A co-treated with Tretinoin] results in decreased expression of SFN mRNA CTD PMID:30951980 bisphenol A affects expression ISO RGD:1312341 6480464 bisphenol A affects the expression of SFN mRNA CTD PMID:30903817 bisphenol A decreases methylation ISO RGD:1312342 6480464 bisphenol A results in decreased methylation of SFN promoter CTD PMID:27312807 bisphenol F multiple interactions ISO RGD:1312342 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of SFN mRNA CTD PMID:30951980 bisphenol F increases expression ISO RGD:1312342 6480464 bisphenol F results in increased expression of SFN mRNA CTD PMID:30951980 bortezomib increases expression ISO RGD:1312341 6480464 Bortezomib results in increased expression of SFN mRNA CTD PMID:20977926 bortezomib multiple interactions ISO RGD:1312341 6480464 [irinotecan co-treated with Bortezomib] results in decreased expression of SFN protein CTD PMID:16373703 bucladesine multiple interactions ISO RGD:1312341 6480464 [Estradiol co-treated with Medroxyprogesterone Acetate co-treated with Bucladesine co-treated with decitabine] results in increased expression of SFN mRNA, [Estradiol co-treated with Medroxyprogesterone Acetate co-treated with Bucladesine] results in increased expression of SFN protein CTD PMID:22534328 butan-1-ol multiple interactions ISO RGD:1312341 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SFN mRNA CTD PMID:29432896 cadmium dichloride increases expression ISO RGD:1312341 6480464 Cadmium Chloride results in increased expression of SFN mRNA CTD PMID:12160620 , PMID:25596134 cadmium dichloride multiple interactions EXP 6480464 [Cadmium Chloride co-treated with diallyl disulfide] results in decreased expression of SFN mRNA CTD PMID:31077537 calcitriol increases expression ISO RGD:1312341 6480464 Calcitriol results in increased expression of SFN mRNA CTD PMID:26485663 carbamazepine affects expression ISO RGD:1312341 6480464 Carbamazepine affects the expression of SFN mRNA CTD PMID:25979313 carbon nanotube affects expression ISO RGD:1312341 6480464 Nanotubes, Carbon affects the expression of SFN protein CTD PMID:22001959 carbon nanotube increases expression ISO RGD:1312342 6480464 Nanotubes more ... CTD PMID:25554681 chlorambucil increases expression ISO RGD:1312341 6480464 Chlorambucil results in increased expression of SFN mRNA CTD PMID:18092340 chloroacetaldehyde increases expression ISO RGD:1312341 6480464 chloroacetaldehyde results in increased expression of SFN mRNA CTD PMID:25596134 chloropicrin decreases expression ISO RGD:1312341 6480464 chloropicrin results in decreased expression of SFN mRNA CTD PMID:26352163 chloroprene increases expression ISO RGD:1312342 6480464 Chloroprene results in increased expression of SFN mRNA CTD PMID:23125180 choline multiple interactions ISO RGD:1312342 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SFN mRNA CTD PMID:20938992 chrysin increases expression ISO RGD:1312341 6480464 chrysin results in increased expression of SFN mRNA, chrysin results in increased expression of SFN protein CTD PMID:18331776 cidofovir anhydrous increases expression ISO RGD:1312341 6480464 Cidofovir results in increased expression of SFN mRNA CTD PMID:25596134 cisplatin decreases expression ISO RGD:1312341 6480464 Cisplatin results in decreased expression of SFN protein CTD PMID:21924258 cisplatin increases expression ISO RGD:1312341 6480464 Cisplatin results in increased expression of SFN mRNA CTD PMID:21532991 more ... cisplatin affects expression ISO RGD:1312341 6480464 Cisplatin affects the expression of SFN mRNA CTD PMID:25450742 cisplatin affects response to substance ISO RGD:1312341 6480464 SFN protein affects the susceptibility to Cisplatin CTD PMID:26894857 cisplatin multiple interactions ISO RGD:1312341 6480464 Cisplatin promotes the reaction [jinfukang results in increased expression of SFN mRNA] more ... CTD PMID:15999354 , PMID:27392435 clodronic acid increases expression ISO RGD:1312341 6480464 Clodronic Acid results in increased expression of SFN mRNA CTD PMID:25596134 copper atom increases expression EXP 6480464 Copper results in increased expression of SFN mRNA CTD PMID:22465980 copper atom multiple interactions ISO RGD:1312341 6480464 [Chelating Agents binds to Copper] which affects the expression of SFN mRNA CTD PMID:30911355 copper atom multiple interactions ISO RGD:1312342 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of SFN mRNA CTD PMID:15467011 copper(0) increases expression EXP 6480464 Copper results in increased expression of SFN mRNA CTD PMID:22465980 copper(0) multiple interactions ISO RGD:1312341 6480464 [Chelating Agents binds to Copper] which affects the expression of SFN mRNA CTD PMID:30911355 copper(0) multiple interactions ISO RGD:1312342 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of SFN mRNA CTD PMID:15467011 copper(II) sulfate increases expression ISO RGD:1312341 6480464 Copper Sulfate results in increased expression of SFN mRNA CTD PMID:19549813 coumestrol multiple interactions ISO RGD:1312341 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SFN mRNA CTD PMID:19167446 coumestrol increases expression ISO RGD:1312341 6480464 Coumestrol results in increased expression of SFN mRNA CTD PMID:19167446 crocidolite asbestos increases expression ISO RGD:1312341 6480464 Asbestos, Crocidolite results in increased expression of SFN protein CTD PMID:29553831 cyclophosphamide increases expression ISO RGD:1312341 6480464 Cyclophosphamide results in increased expression of SFN mRNA CTD PMID:21527772 cyclosporin A increases expression ISO RGD:1312341 6480464 Cyclosporine results in increased expression of SFN mRNA CTD PMID:20106945 more ... cytarabine decreases response to substance ISO RGD:1312341 6480464 SFN protein results in decreased susceptibility to Cytarabine CTD PMID:25189999 diallyl disulfide multiple interactions EXP 6480464 [Cadmium Chloride co-treated with diallyl disulfide] results in decreased expression of SFN mRNA CTD PMID:31077537 diarsenic trioxide decreases response to substance ISO RGD:1312341 6480464 SFN protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of SFN mRNA CTD PMID:21266533 diclofenac increases expression ISO RGD:1312341 6480464 Diclofenac results in increased expression of SFN mRNA CTD PMID:17379860 diethylstilbestrol increases expression ISO RGD:1312342 6480464 Diethylstilbestrol results in increased expression of SFN mRNA CTD PMID:15171707 , PMID:16636312 dioxygen increases expression ISO RGD:1312341 6480464 Oxygen deficiency results in increased expression of SFN mRNA CTD PMID:25596134 dioxygen multiple interactions ISO RGD:1312342 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SFN mRNA CTD PMID:30529165 dorsomorphin multiple interactions ISO RGD:1312341 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:1312341 6480464 Doxorubicin results in increased expression of SFN protein CTD PMID:24816189 doxorubicin affects response to substance ISO RGD:1312341 6480464 SFN protein affects the susceptibility to Doxorubicin CTD PMID:26894857 doxorubicin multiple interactions ISO RGD:1312341 6480464 TP53 protein mutant form affects the reaction [Doxorubicin results in decreased expression of SFN mRNA], TP53 protein mutant form affects the reaction [Doxorubicin results in increased expression of SFN protein] CTD PMID:24816189 doxorubicin decreases expression ISO RGD:1312341 6480464 Doxorubicin results in decreased expression of SFN mRNA CTD PMID:24816189 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of SFN mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO RGD:1312341 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SFN mRNA CTD PMID:19167446 entinostat increases expression ISO RGD:1312341 6480464 entinostat results in increased expression of SFN mRNA CTD PMID:27188386 ethanol multiple interactions ISO RGD:1312341 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SFN mRNA CTD PMID:29432896 ethyl methanesulfonate increases expression ISO RGD:1312341 6480464 Ethyl Methanesulfonate results in increased expression of SFN mRNA CTD PMID:23649840 etoposide increases expression ISO RGD:1312341 6480464 Etoposide results in increased expression of SFN mRNA CTD PMID:21527772 folic acid multiple interactions ISO RGD:1312342 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SFN mRNA more ... CTD PMID:20938992 , PMID:22206623 formaldehyde increases expression ISO RGD:1312341 6480464 Formaldehyde results in increased expression of SFN mRNA CTD PMID:23649840 gefitinib decreases expression ISO RGD:1312341 6480464 gefitinib results in decreased expression of SFN mRNA CTD PMID:16685379 gemcitabine affects response to substance ISO RGD:1312341 6480464 SFN protein affects the susceptibility to gemcitabine CTD PMID:26894857 gemcitabine decreases response to substance ISO RGD:1312341 6480464 SFN protein results in decreased susceptibility to gemcitabine CTD PMID:25189999 , PMID:26894857 gemcitabine increases methylation ISO RGD:1312341 6480464 gemcitabine results in increased methylation of SFN gene CTD PMID:25189999 gemcitabine multiple interactions ISO RGD:1312341 6480464 [DNMT1 protein binds to SFN promoter] inhibits the reaction [gemcitabine results in decreased susceptibility to gemcitabine] more ... CTD PMID:25189999 , PMID:26894857 GW 4064 increases expression ISO RGD:1312341 6480464 GW 4064 results in increased expression of SFN mRNA CTD PMID:31437187 hydroquinone increases expression ISO RGD:1312341 6480464 hydroquinone results in increased expression of SFN mRNA CTD PMID:23940045 hydroquinone multiple interactions ISO RGD:1312341 6480464 [hydroquinone affects the methylation of SFN promoter] which results in decreased abundance of 5-Methylcytosine more ... CTD PMID:23940045 hydroquinone affects methylation ISO RGD:1312341 6480464 hydroquinone affects the methylation of SFN promoter CTD PMID:23940045 ibuprofen increases expression ISO RGD:1312341 6480464 Ibuprofen results in increased expression of SFN mRNA CTD PMID:25596134 ifosfamide increases expression ISO RGD:1312341 6480464 Ifosfamide results in increased expression of SFN mRNA CTD PMID:25596134 irinotecan multiple interactions ISO RGD:1312341 6480464 [Irinotecan co-treated with Bortezomib] results in decreased expression of SFN protein CTD PMID:16373703 isobutanol multiple interactions ISO RGD:1312341 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SFN mRNA CTD PMID:29432896 isoniazide decreases expression ISO RGD:1312341 6480464 Isoniazid results in decreased expression of SFN mRNA CTD PMID:30008028 isoprenaline decreases expression ISO RGD:1312341 6480464 Isoproterenol results in decreased expression of SFN mRNA CTD PMID:24286936 ivermectin decreases expression ISO RGD:1312341 6480464 Ivermectin results in decreased expression of SFN protein CTD PMID:32959892 kaempferol increases expression ISO RGD:1312341 6480464 kaempferol results in increased expression of SFN mRNA, kaempferol results in increased expression of SFN protein CTD PMID:18331776 L-methionine multiple interactions ISO RGD:1312342 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SFN mRNA CTD PMID:20938992 Lasiocarpine increases expression ISO RGD:1312341 6480464 lasiocarpine results in increased expression of SFN mRNA CTD PMID:32234424 lead diacetate decreases expression ISO RGD:1312342 6480464 lead acetate results in decreased expression of SFN mRNA CTD PMID:20680508 Licochalcone B increases expression ISO RGD:1312341 6480464 licochalcone B results in increased expression of SFN mRNA CTD PMID:33647349 luteolin increases expression ISO RGD:1312341 6480464 Luteolin results in increased expression of SFN mRNA, Luteolin results in increased expression of SFN protein CTD PMID:18331776 medroxyprogesterone acetate multiple interactions ISO RGD:1312341 6480464 [Estradiol co-treated with Medroxyprogesterone Acetate co-treated with Bucladesine co-treated with decitabine] results in increased expression of SFN mRNA, [Estradiol co-treated with Medroxyprogesterone Acetate co-treated with Bucladesine] results in increased expression of SFN protein CTD PMID:22534328 mercury dibromide increases expression ISO RGD:1312341 6480464 mercuric bromide results in increased expression of SFN mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1312341 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA CTD PMID:27188386 metformin increases expression EXP 6480464 Metformin results in increased expression of SFN mRNA CTD PMID:25596134 methotrexate increases expression ISO RGD:1312341 6480464 Methotrexate results in increased expression of SFN mRNA CTD PMID:17379860 , PMID:21678067 methyl methanesulfonate increases expression ISO RGD:1312341 6480464 Methyl Methanesulfonate results in increased expression of SFN mRNA CTD PMID:21527772 , PMID:23649840 methylmercury chloride increases expression ISO RGD:1312341 6480464 methylmercuric chloride results in increased expression of SFN mRNA CTD PMID:28001369 mitoxantrone affects response to substance ISO RGD:1312341 6480464 SFN protein affects the susceptibility to Mitoxantrone CTD PMID:16217747 monosodium L-glutamate decreases expression EXP 6480464 Sodium Glutamate results in decreased expression of SFN mRNA CTD PMID:28954212 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine increases expression ISO RGD:1312341 6480464 N more ... CTD PMID:18778698 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine multiple interactions ISO RGD:1312341 6480464 TP53 mutant form inhibits the reaction [N more ... CTD PMID:18778698 N-methyl-4-phenylpyridinium increases expression ISO RGD:1312342 6480464 1-Methyl-4-phenylpyridinium results in increased expression of SFN protein CTD PMID:26558463 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of SFN mRNA CTD PMID:28801915 N-nitrosodiethylamine multiple interactions ISO RGD:1312342 6480464 [3 more ... CTD PMID:23457121 N-nitrosodimethylamine increases expression ISO RGD:1312341 6480464 Dimethylnitrosamine results in increased expression of SFN mRNA CTD PMID:17547211 N-Nitrosopyrrolidine increases expression ISO RGD:1312341 6480464 N-Nitrosopyrrolidine results in increased expression of SFN mRNA CTD PMID:32234424 naphthalene increases expression ISO RGD:1312342 6480464 naphthalene results in increased expression of SFN mRNA CTD PMID:18978301 nickel atom increases expression ISO RGD:1312341 6480464 Nickel results in increased expression of SFN mRNA CTD PMID:25583101 nickel sulfate increases expression ISO RGD:1312342 6480464 nickel sulfate results in increased expression of SFN mRNA CTD PMID:16100012 , PMID:16166746 obeticholic acid decreases expression ISO RGD:1312341 6480464 obeticholic acid results in decreased expression of SFN mRNA CTD PMID:27939613 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of SFN mRNA CTD PMID:19237604 ochratoxin A decreases expression ISO RGD:1312341 6480464 ochratoxin A results in decreased expression of SFN mRNA CTD PMID:30008028 , PMID:30559759 ozone increases expression ISO RGD:1312342 6480464 Ozone results in increased expression of SFN mRNA CTD PMID:12763052 , PMID:17095637 ozone multiple interactions ISO RGD:1312342 6480464 [NOTCH3 gene mutant form affects the susceptibility to Ozone] which results in increased expression of SFN mRNA CTD PMID:25658374 p-chloromercuribenzoic acid increases expression ISO RGD:1312341 6480464 p-Chloromercuribenzoic Acid results in increased expression of SFN mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:1312341 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA CTD PMID:27188386 panobinostat multiple interactions ISO RGD:1312341 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:1312341 6480464 panobinostat results in increased expression of SFN mRNA CTD PMID:26272509 paracetamol decreases expression ISO RGD:1312341 6480464 Acetaminophen results in decreased expression of SFN mRNA CTD PMID:21420995 , PMID:29067470 paracetamol increases expression ISO RGD:1312341 6480464 Acetaminophen results in increased expression of SFN mRNA CTD PMID:22230336 paraquat increases expression EXP 6480464 Paraquat results in increased expression of SFN mRNA CTD PMID:32680482 perfluorononanoic acid decreases expression ISO RGD:1312341 6480464 perfluoro-n-nonanoic acid results in decreased expression of SFN mRNA CTD PMID:32588087 phenylmercury acetate increases expression ISO RGD:1312341 6480464 Phenylmercuric Acetate results in increased expression of SFN mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1312341 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA CTD PMID:27188386 pirinixic acid decreases expression ISO RGD:1312342 6480464 pirinixic acid results in decreased expression of SFN mRNA CTD PMID:17426115 potassium bromate increases expression ISO RGD:1312341 6480464 potassium bromate results in increased expression of SFN mRNA CTD PMID:30008028 , PMID:30559759 progesterone decreases expression ISO RGD:1312342 6480464 Progesterone results in decreased expression of SFN mRNA CTD PMID:16966611 progesterone multiple interactions ISO RGD:1312342 6480464 [Estradiol co-treated with Progesterone] results in increased expression of SFN mRNA CTD PMID:18556351 progesterone increases phosphorylation EXP 6480464 Progesterone results in increased phosphorylation of SFN protein CTD PMID:17303654 quercetin increases expression ISO RGD:1312341 6480464 Quercetin results in increased expression of SFN mRNA, Quercetin results in increased expression of SFN protein CTD PMID:14750173 more ... SB 431542 multiple interactions ISO RGD:1312341 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silver atom increases expression ISO RGD:1312342 6480464 Silver results in increased expression of SFN mRNA CTD PMID:27131904 silver(0) increases expression ISO RGD:1312342 6480464 Silver results in increased expression of SFN mRNA CTD PMID:27131904 sodium arsenite decreases expression ISO RGD:1312341 6480464 sodium arsenite results in decreased expression of SFN mRNA CTD PMID:12760830 sodium arsenite increases expression ISO RGD:1312341 6480464 sodium arsenite results in increased expression of SFN mRNA CTD PMID:29301061 , PMID:34032870 sodium fluoride increases expression ISO RGD:1312342 6480464 Sodium Fluoride results in increased expression of SFN protein CTD PMID:27548804 sulforaphane affects binding ISO RGD:1312341 6480464 SFN protein binds to sulforaphane CTD PMID:21838287 tamoxifen increases expression ISO RGD:1312342 6480464 Tamoxifen results in increased expression of SFN mRNA CTD PMID:17555576 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of SFN mRNA CTD PMID:30723492 tetraphene decreases expression ISO RGD:1312342 6480464 benz(a)anthracene results in decreased expression of SFN mRNA CTD PMID:26377693 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of SFN mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:1312342 6480464 titanium dioxide results in increased expression of SFN mRNA CTD PMID:23409001 , PMID:27760801 tributylstannane increases expression ISO RGD:1312342 6480464 tributyltin results in increased expression of SFN mRNA CTD PMID:31939706 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of SFN mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:1312341 6480464 trichostatin A results in increased expression of SFN mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1312341 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA CTD PMID:27188386 Triptolide increases expression ISO RGD:1312342 6480464 triptolide results in increased expression of SFN mRNA, triptolide results in increased expression of SFN protein CTD PMID:26990902 , PMID:32835833 urethane decreases expression ISO RGD:1312341 6480464 Urethane results in decreased expression of SFN mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:1312341 6480464 Valproic Acid affects the expression of SFN mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1312341 6480464 Valproic Acid results in increased expression of SFN mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:1312341 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA CTD PMID:27188386 vorinostat multiple interactions ISO RGD:1312341 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA CTD PMID:27188386 zinc atom multiple interactions ISO RGD:1312341 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of SFN mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:1312341 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of SFN mRNA CTD PMID:18593933
